Trials / Withdrawn
WithdrawnNCT04100889
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- ProgenaBiome · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Alzheimer's disease.
Detailed description
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding Alzheimer's disease.
Conditions
- Alzheimer Disease
- Alzheimer Disease 1
- Alzheimer Disease 2
- Alzheimer Disease 3
- Alzheimer Disease 4
- Alzheimer Disease 5
- Alzheimer Disease 6
- Alzheimer Disease 7
- Alzheimer Disease 8
- Alzheimer Disease 9, Late-Onset
- Alzheimer Disease 10
- Alzheimer Disease 11
- Alzheimer Disease 12
- Alzheimer Disease 13
- Alzheimer Disease 14
- Alzheimer Disease 15
- Alzheimer Disease 16
- Alzheimer Disease 17
- Alzheimer Disease 18
- Alzheimer Disease 19
- Alzheimer Disease, Early Onset
- Alzheimer Disease, Late Onset
- Alzheimer Disease Focal
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | There is no intervention for this study. |
Timeline
- Start date
- 2020-03-02
- Primary completion
- 2030-03-01
- Completion
- 2030-07-01
- First posted
- 2019-09-24
- Last updated
- 2025-06-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04100889. Inclusion in this directory is not an endorsement.